Showcasing as a Knowledge-based full services CRO: Insights on Pharmacovigilance and Precision Medicine

At Navitas Life Sciences, we believe in not just advancing the frontiers of pharmaceutical sciences but also in giving back to society and academia.
Dr Latika Sharma, MBBS., MD, our PV Networks Lead, led an insightful seminar as a part of clinical research & pharmacovigilance training on “Pharmacovigilance: Trends, Opportunities & Challenges,” for the Department of Pharmacology at Saveetha Medical College , together with the Interested Persons’ Conclave Trust (IntPCON). This event underscored our commitment to public health, education, and the continuous improvement of drug safety practices.

In addition, Dr Akash Gadgade, our Associate Director of Medical and Scientific Affairs, presented on “Precision Medicine and Personalized Treatment Plans with Artificial Intelligence” at the National Pharmacology CME 2024 event hosted by Jawaharlal Nehru Medical College, highlighting the intersection of precision medicine and artificial intelligence.

In this blog, we look at highlights of both the pharmacovigilance seminar and the precision medicine presentation, to capture the immense insights and to continue to spread knowledge.

Dr. Latika Sharma, MBBS, MD

PV Networks Lead
Consulting and Networks,

Navitas Life Sciences

Dr Latika Sharma is a trained post graduate physician with over 20 years of experience spanning medical practice, military services, academia, and industry. She was attracted to the concept of clinical research/epidemiology and its potential to positively impact ‘populations’ rather than individual patients, one at a time. Her interest in pharmacology, public health, and research made PV a great choice and she started her career as a medical review manager leading a medical review team, followed by building/heading up a full-fledged PV practice. She is currently a Strategic Thoughtlead & Senior Managing Consultant, leading PV networks at Navitas Life Sciences.

Latika’s presentation on Pharmacovigilance was to a large group of over 200 participants from academia and industry who deeply appreciated the insights shared.

Pharmacovigilance: Trends, Opportunities & Challenges

Pharmacovigilance, as defined by the World Health Organization (WHO), is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. Latika Sharma’s seminar focused on key concepts of pharmacovigilance, highlighting its critical role in ensuring the safety and efficacy of medicinal products across their life cycle.

Key Takeaways from the presentation:

• The seminar began with a historical perspective, emphasizing the lessons learned from past events like the Thalidomide tragedy and the introduction of the spontaneous reporting system.
• Key historical cases like the safety issues with Practolol, Benoxaprofen, and Rofecoxib were discussed to illustrate the evolution and advancements in pharmacovigilance.

Where lie the Opportunities and Challenges?

Latika highlighted the modern challenges in pharmacovigilance, including the detection of adverse drug reactions (ADRs), the need for robust causality assessment methods, and the varying rigor in risk management plans across different regions.

Opportunities such as leveraging technology for data capture and signal detection and focusing on vulnerable populations like pregnant women and pediatric patients were also discussed.

Future Trends and Implications:

The seminar shed light on the future of pharmacovigilance in the context of shifting demographics, new healthcare economies, and dynamic portfolios. Role of healthcare professionals in counselling/treatment, detection and reporting of adverse events is fundamental in a large and heterogenous society like India. Empowered patients, social media and digital native talent will shape the future of PV. The impact of emerging technologies like artificial intelligence, cloud computing, and advanced analytics on pharmacovigilance processes was explored. Regulatory trends and the importance of harmonizing regional regulations to ensure global drug safety were emphasized.

Navitas Life Sciences’ Pharmacovigilance Services

Navitas Life Sciences has over 30 years of experience in Pharmacovigilance. Patient safety has always been a critical concern, and today, the remit of safety has expanded, making it a crucial component in core processes for Life Sciences companies. Consequently, our expert drug safety team focuses on core activities throughout the product life cycle to ensure better risk management and effective market interventions. In the face of growing regulatory and compliance expectations, achieving greater efficiency is essential. As a part of our end-to-end pharmacovigilance services, we leverage technology to automate processes, use data to drive insights, and improve efficiencies while supporting the safety profile of drugs.

Dr. Akash Gadgade, MBBS, MD

Associate Director -
Medical and Scientific Affairs,

Navitas Life Sciences

Dr. Akash Gadgade is a medical doctor with over 10 years of experience in the pharmaceutical industry, clinical research organisation and academia. He completed his medical education (MBBS and MD) at top medical schools in India. Dr Gadgade has presented research papers at national and international conferences, published articles in reputable journals, and worked with leading sponsors as well as CRO companies in India on various clinical trials.

Precision Medicine and Personalized Treatment Plans with Artificial Intelligence

Dr Akash Gadgade's presentation at the National Pharmacology CME event focused on the role of artificial intelligence in precision medicine and personalized treatment plans.

Key topics discussed during the session include

Basics of Precision Medicine:

• Comparison between precision medicine and traditional medicine.
• Role of AI in enhancing personalized healthcar

Precision Medicine and Public Health:

• Utilizing AI for big data analysis and personalized health promotion.
• Impact on chronic disease prevention, diagnosis, and treatment.

AI in Cardiology and Surgery:

• Early research into AI for coronary artery assessment.
• Innovations in autonomous robotic surgery and predictive analytics.

Medical Genomics:

• Exome sequencing and individual risk assessments for disease.
• Personalized treatment responses and prognostic evaluations.

Commitment to Society and Academia: Spreading Knowledge

At Navitas Life Sciences, our commitment to advancing pharmaceutical sciences is exemplified through our active engagement with both society and academia. By hosting seminar sessions like Dr. Latika Sharma's on Pharmacovigilance and Dr. Akash Gadgade's on precision medicine, we continue our pursuit to share valuable insights and enhance learning within the community.

We firmly believe that sharing insights and knowledge are essential to encourage continued innovation and growth. Offering visibility into our clinical trial trends and upcoming features and capabilities allows our partners and clients to anticipate how our offerings will evolve to meet their future needs. This enables our stakeholders to influence the direction of our innovations, ensuring that our solutions align with their strategic goals and customer insights. Such communication and collaboration are particularly vital given the dynamic nature of pharmacovigilance and clinical research.

Showcasing Our Industry-Leading Networks

Our commitment to knowledge sharing is further evident in our great support for peer-to-peer networking. Staying connected is crucial for sharing insights, exploring trends, and navigating regulatory changes. This is why we have cultivated a vibrant community designed to empower professionals worldwide. Our industry-leading Pharmacovigilance and Regulatory networks offer transformative benefits that drive innovation, productivity, and growth.

Gaining Key Insights at Pharma Networking Events

Founded in 2001, our networks are the premier platforms for engaging in discussions about trends, insights, and future solutions within the pharmaceutical industry. They provide an opportunity for our 110+ member companies to examine complex problems from various perspectives, gaining a competitive advantage and contributing to their organizations. By leveraging collective intelligence, our networks generate data-driven insights that lead to transformative actions and foster industry growth.

Pharma networking events are the cornerstone of our networks. These events, held in locations such as the UK, USA, and India, as well as virtual forums, provide a platform for like-minded individuals to converge, exchange ideas, and forge meaningful partnerships. They offer unique opportunities to expand horizons and stay ahead of the curve.

By joining our networks, you become part of a dynamic community that supports your professional growth and helps you navigate the complexities of the pharmaceutical industry.

Join Our Premier Networks and Elevate Your Expertise!

Connect, learn, and lead in the pharmaceutical industry.

Become a member of Navitas Life Sciences' industry-leading networks and gain access to cutting-edge insights, exclusive events, and a vibrant community of professionals.

Grow with the Knowledge and Insights

Our industry-leading networks offer the tools, connections, and knowledge you need to excel.

Become a Member TODAY and benefit from the Knowledge shared

To become a member, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

Our ongoing efforts in education, research, and community engagement highlight our dedication to making a positive impact on society and advancing the field of clinical research. Our collaborations with biotech, pharma, academic institutions, and U.S. Federal organizations ensure that we stay ahead and contribute to the advancement of scientific discoveries.

Dr Latika Sharma’s seminar and Dr Akash Gadgade’s presentation are a way of giving back to society and academia. Through our continued efforts in education, research, and community engagement, we would like to empower society and enhance understanding.

To learn more about our services and solutions, reach out to us at This email address is being protected from spambots. You need JavaScript enabled to view it.